• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

    0.1593 +0.0023 (+1.46%)
    Delayed Quote Updated: 3:14 PM EDT, Oct 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 861,633
    Open 0.1560
    Bid (Size) 0.1588 (4,500)
    Ask (Size) 0.1606 (900)
    Prev. Close 0.1570
    Today's Range 0.1550 - 0.1634
    52wk Range 0.1440 - 2.780
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
    Proposed seamless design would incorporate previously FDA-cleared dose-optimization work into a single registration-intent program aligning it with Company’s capital-efficient development strategy 
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
    Decision advances Company’s previously announced capital-efficient development strategy by concentrating resources on FDA-authorized, SKNJCT-005, NDA-enabling, Registrational Phase 2b Study in Gorlin... 
    From Medicus Pharma Ltd
    Via GlobeNewswire

    Performance

    52-Week Range 94.3% below 52-week high
    0.1593
    0.1452W Low 2.7852W High
    1 Week 5.4% below 1-week high
    0.151W Low 0.171W High

    Medicus Pharma Ltd. - Common Stock (MDCX) traded between $0.14 and $2.78 over the past 52 weeks and last traded at $0.16, 94.3% below its 52-week high. Over the past week it ranged between $0.15 and $0.17.

    Past 12 Months
    +4.5%
    -36.6%
    -61.7%
    -64.4%
    -90.0%
    -92.9%
    1W +$0.01
    1M -$0.09
    3M -$0.26
    6M -$0.29
    YTD -$1.44
    1Y -$2.08

    MDCX was -92.9% over the past year, -64.4% over six months, -90.0% year to date, +4.5% in the last week.

    12 Months vs Market
    MDCX
    -92.9%
    DIA
    +10.0%
    SPY
    +15.1%
    QQQ
    +24.1%
    IWM
    +16.1%

    Over the past 12 months MDCX returned -92.9% versus DIA (Dow) +10.0%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.1% and IWM (Russell 2000) +16.1%.

    Volume & Liquidity 0.20× 3-mo avg
    Today 861,633 3-mo avg 4.3M
    1W
    1.6M
    1M
    9.8M
    3M
    4.3M
    6M
    4.2M
    YTD
    4.1M
    1Y
    3.1M

    MDCX most recently traded 861,633 shares against a 3-month average daily volume of 4.3M.

    More News

    Read More
    Unusual volume stocks are being observed in Thursday's session. ↗
    Via Chartmill
    News headline image
    Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
    From Medicus Pharma Ltd
    Via GlobeNewswire
    Unusual volume stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
    From Medicus Pharma Ltd
    Via GlobeNewswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Check out the stocks that are attracting the most attention and driving market activity. ↗
    Via Chartmill
    Thursday's session: top gainers and losers ↗
    Via Chartmill
    Gapping stocks in Thursday's session ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    From Medicus Pharma Ltd
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
    From New to The Street
    Via ACCESS Newswire
    Top movers in Friday's after hours session ↗
    Via Chartmill
    News headline image
    Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
    From New to The Street
    Via ACCESS Newswire
    News headline image
    Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
    From New to The Street
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Medicus Pharma Ltd. - Common Stock publicly traded?
    Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
    What exchange does Medicus Pharma Ltd. - Common Stock trade on?
    Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
    The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
    What is the current price of Medicus Pharma Ltd. - Common Stock?
    The current price of Medicus Pharma Ltd. - Common Stock is 0.1593
    When was Medicus Pharma Ltd. - Common Stock last traded?
    The last trade of Medicus Pharma Ltd. - Common Stock was at 10/02/26 03:14 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.